In a pilot study of five HIV-infected participants on ART, Romidepsin treatment was associated with a modest reduction in cytokine production by HIV-specific CD8+ T-cells that did not reach statistical significance ( 10 ).
← all excerpts
Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure.
1
—
—